Background: The occurrence of a brain tumor or intracranial vascular lesion during pregnancy is a rare event, but when it happens, it jeopardizes the lives of both the mother and infant. It also creates challenges of a neurosurgical, obstetric, and ethical nature. A multidisciplinary approach should be used for their care. Results: Among 12 patients presenting with brain tumors, there were neither operative mortality nor fetal deaths. Among the vascular lesions, aneurysm rupture was responsible for bleeding in 6 instances. Arteriovenous malformation was diagnosed in 7 patients. In this subgroup, the maternal and fetal mortality rates were 11.7% and 23.7%, respectively. Conclusions: We can assert that the association between a brain tumor and vascular lesions with pregnancy is a very unusual event, which jeopardizes both the lives of the mother and infant. It remains incompletely characterized due to the rare nature of these potentially devastating events. Knowing the exact mechanism responsible for the interaction of pregnancy and with these lesions will improve the treatment of these patients.
INTRODUCTION
The occurrence of a brain tumor or intracerebral hemorrhage during pregnancy poses risks to both the mother and infant, and presents unique challenges to the neurosurgeon. There are few data on the risks of pregnancy in women with these diseases and no clear guidelines regarding its management during pregnancy, delivery, and puerperium. [6, 12, 13, 20, 32, 38, 39, 40] This study aims at identifying the best medical and surgical procedures to be followed for a pregnant patient harboring a brain tumor or an intracranial vascular lesion.
MATERIALS AND METHODS

Data collection
A retrospective study was performed to evaluate 29 pregnant patients with concomitant intracranial lesions treated between January 1986 and January 2015.
We will analyze the two groups of patient's separately; 12 consecutive pregnant women diagnosed with brain tumors and 17 patients with vascular lesion underwent treatment in the Neurosurgery Department at the authors' institutions. The Obstetrics Department of Hospital Federal dos Servidores do Estado (HFSE) is a reference center for high-risk pregnant patients in the city of Rio de Janeiro. All the postoperative care was carried out at the intensive care unit (ICU), a unit with a long history of high-risk pregnancy management. Medical records, surgical descriptions, imagings studies, and the histopathological material were reviewed, thereby creating a database from which information pertinent to the present study was collected. The intraoperative videos and/or photos of 15 patients were analyzed for nuances of the microsurgical technique. The Neurosurgery Department teamed up with Obstetrics, Psychology, and Anesthesiology Departments, as well as with families and patients themselves, for establishing the procedures. The need for informed consent was waived due to the retrospective nature of the study. The first visit in the pediatric, obstetric, and neurosurgery clinics was approximately 15 days after hospital discharge and then after 2 and 6 months, and thereafter, patients were reexamined at 1-year intervals until the fifth postoperative year. The Glasgow Outcome Scale (GOS) defined the neurological outcome. The mengiomas and astrocytomas tumors grading are consistent with the World Health Organization (WHO) classification.
In this series, we performed 9 craniotomies during pregnancy (5 for tumors and 4 for vascular lesions). In all cases, a meticulous neurosurgical dissection with microsurgical removal of the tumor or aneurysms occlusion was successfully carried out without any deleterious effect on the mother or baby. However, a number of special cautionary steps were taken:
• Operative Positioning -The pregnant uterus should not compress the inferior vena cava because this leads to a decrease in the venous return, causing arterial hypotension and shock. The dorsal decubitus position, with a trunk rotation to the left, leaned on a roll, prevents aortocaval compression. When the lesion is located on the posterior fossa, the ventral decubitus position is disallowed • Anesthesia -Anesthetic consideration involves safety of the mother and fetus. 
RESULTS
Neoplastic lesions
There were 12 patients with ages varying from 25 to 37 years (average, 31 years). The gestational age varied from 16 to 40 weeks (average, 29.7 weeks). The symptoms, location of the tumors, surgical resection extension, and other pertinent information are presented in Table 1 . The 12 pregnant patients underwent a neurosurgical intervention, and no surgical maternal death occurred in this series. One patient diagnosed with metastatic melanoma died due to melanoma dissemination, 8 months following craniotomy. No fetal deaths were observed. Eight patients had cesarean section (CS) deliveries prior to craniotomy, 3 others had vaginal deliveries (VD) during the postoperative period, and in one woman, a spontaneous abortion occured. In this sample, histological diagnosis revealed 4 grade 2 astrocytomas, all of which had a gross total removal (GTR). Three patients (75%) developed dedifferentiation varying from 12 to 46 months; and 2 of them died during the follow-up period. We also detected 1 grade 2 oligodendroglioma, 3 grade 1 meningiomas, 1 melanoma metastasis, 1 epidermoid tumor [ Figure 1a and b]; 1 case of chemodectoma and 1 patient with a pituitary apoplexy in a non-function adenoma.
Vascular lesions
The patients' ages varied from 17 to 39 years (average, 28 years). Six patients harbored intracranial aneurysms, Two patients, although undergoing prompt surgical removal of massive intracerebral hematomas, had an unfavorable evolution. Among the 4 patients with eclampsia, two died due to aspiration complication and sepsis. We documented 6 fetal deaths. The presenting symptoms and other clinical features are summarized in Table 2 .
DISCUSSION
Neoplastic and vascular lesions in pregnant patients have some features in common along with some differences; understanding these differences and nuances is essential to choose the most appropriate medical treatment for these patients.
Neoplastic lesions
The occurrence of a brain tumor during pregnancy is a rare event. [12, 13, 29, 27, 16, 31, 32, 39, 40] Isla et al. [19] observed only 7 women with brain tumor in a series of 126,413 pregnancies. In addition to putting at risk the lives of both the mother and infant, this association represents a real therapeutic challenge. [6, 12, 13, 20, 32, 38, 39, 40] It is, therefore, fundamental that a multidisciplinary care team approach be established. [7, 6, 32, 39, 40] Different histological types of brain tumors associated with pregnancy were described. [6, 12, 13, 20, 26, 29, 30, 36, 37, 39, 40] In this series as well as in others, [6, 12, 20, 32, 37, 39] the gliomas were the most prevalent aforementioned factors, we could establish five different clinical scenarios:
• If the patient presents stable neurological conditions, the neurosurgery may be deferred until gestational period reaches the 30 th week. After that, the delivery can be either a VD or a CS, depending exclusively on the obstetric criteria. The craniotomy in this situation is an elective procedure to be performed after the delivery. This was the case of 3 patients • If the patient presents with brain edema, but is neurologically stable, cortisone is prescribed to control the cerebral edema as well as to accelerate fetal lung maturity. When the fetus lungs are mature, delivery is performed, followed by an elective craniotomy for tumor removal. This was the procedure for 2 patients • If aggravation of neurological symptoms occurs during the fetal maturation period, craniotomy is performed immediately. CS is done just before or after craniotomy. This was an alternative for 1 patient • When the patient presents with sudden or severe neurological conditions or has intracranial hypertension, surgery is immediately performed to save the life of the mother. Both gestation and delivery will have routine postoperative follow-up. This was the case of 3 patients • If a malignant glioma is suspected, a microsurgical tumor removal should be performed as soon as possible, regardless of gestational age, and not delayed until the postpartum period with risk of disease progression in the meantime. [12, 20] If adjuvant chemotherapy is to be ordered and gestation is in the first trimester, therapeutic abortion can be considered because chemotherapy may cause severe damage to the formation of the fetus. Brain radiotherapy can be cautiously utilized in cases of high-grade gliomas. The use of additional shielding is valuable. [12, 13, 20] We strongly advocate multidisciplinary counsel to individualize and optimize the decision-making process. We believe that pregnant women with brain tumors can be treated just as effectively as non-pregnant women. histological type; the meningiomas were the second more frequent. In our material, four cases of astrocytomas were detected. Three of them (75%) developed dedifferentiation in the mean period of 27 months. This suggests that sex hormones occurring during gestation may have an effect on tumor growth, recurrence, and dedifferentiation. [24, 28] Blaauw et al. [4] studied 67 meningiomas and they found progesterone receptor (PR) in more than 80% of the specimens. Hsu et al. [18] and Lesch and Fahlbusch [25] reported nuclear staining for PR of the material examined in 83% and 76%, respectively. These studies suggest that meningiomas may be targets of the progesterone action, which would explain the development, and even the appearance, of meningiomas during gestation. [15, 27] Otherwise, Erik et al. [14] believe that the rapid tumor growth that occurs in some meningiomas is more often due to water retention and engorgement of the intracranial vessels rather than hormone-induced cellular proliferation.
Treatment should always preserve the mother's life and, secondarily, the life of the embryo. Analyzing the
Vascular lesions
SAH is rare among pregnant women and the occurrence rate varies from 0.002 to 0.05% of all pregnancies. [2, 5, 7, 8, 10, 11, 31, 32, 34] Intracranial hemorrhage is responsible for 4-12% of all maternal deaths during pregnancy. [1, 3, 8, 35] Maternal mortality may be as high as 35% to 80% for aneurysmal and 28% for AVM-related hemorrhages. [5, 7, 11, 34, 35] There is an increased propensity for aneurysms bleeding with advancing gestational age. The association between hemodynamic changes during pregnancy and intracranial hemorrhage probably occurs because of maternal blood volume, arterial blood pressure, and venous pressure progressively increasing during pregnancy, reaching the maximum at the end of the third trimester. [5, 11, 34, 35] In our material, in all 6 patients, subarachnoid hemorrhage secondary to rupture cerebral aneurysm occurred in the second trimester of gestation. Only10% of our aneurysms bled in the first trimester, however, none in this series. Surprisingly, it is very unusual to observe aneurysm rupture during labor. [3] Dias and Sekhar [10] reviewed treatment of 106 pregnant patients with aneurysms brain hemorrhage. In their surgical group, the maternal mortality rate was 11%, while in the conservative treatment group, it was 63%. They concluded that surgical treatment is superior to the clinical treatment and recommended surgery, regardless of the pregnancy stage. Pool [33] and Robison et al. among others follow the same principles. [1, 5] In our series, 6 patients underwent microsurgical repair of their aneurysms during pregnancy. No maternal deaths were observed in this group. In our sample, CS occurred in 47% of the cases and VD in 17.6%. Kim et al. [23] observed that CS in pregnant patients with aneurysms is significantly higher than in the general population. The usual microsurgical techniques should be employed, however, inducing hypotension during dissection or clipping of the aneurysm should be avoided. One should preferably utilize the temporary arterial clipping for dissection and final aneurysm occlusion. Endovascular occlusion of the aneurysm is an attractive alternative for aneurysm treatment, however, this was not used in this series.
The appropriate treatment in pregnant patients with MAV is conflicting. [10, 16, 17, 22, 23, 33] Horton et al. [17] studied 343 MAVs patients and concluded that pregnancy does not increase the risk of bleeding. Others surgeons claim an opposite view. [33] Dias and Sekhar [10] reviewed 35 cases in the literature of intracranial hemorrhage from AVMs, and observed that maternal mortality rate was the same after surgical or clinical treatment, concluding that the treatment should be elected on a case-by-case basis. The appropriate delivery for gravid patients with untreated AVMs remains undefined, given the small sample size in published series. Robinson et al. [33] advocate CS at the 38 th week of pregnancy. Sawin et al. [34] and others, [23] state that either VD or CS can be chosen based on obstetrical reasons only. Three of our MAVs patients were operated on after the CS delivery.
Kalani and Zabramski [21] studied the risk for symptomatic hemorrhage from a CCM during pregnancy. They claimed that the risk of symptomatic hemorrhage from a CCM during pregnancy is not increased and a history of CCM is not a contraindication to pregnancy or vaginal delivery. The single patient with a 4 th ventricle CCM had it explored but not removed due to its critical location [ Figure 4a and b]. Four patients with intracranial bleeding due to eclampsia were treated nonoperatively.
In the future, better-powered studies will hopefully enable more high-level recommendations for managing patients with neoplastic or vascular brain lesions presenting during pregnancy.
CONCLUSIONS
We can assert that the association between a brain tumor and vascular lesions during pregnancy is an unusual event, which jeopardizes both the life of the mother and infant and creates challenges of a neurosurgical, obstetric, and ethical nature. Therefore, a multidisciplinary approach should be used for their care. When aneurysm SAH occurs, microsurgery clipping or endovascular occlusion of the aneurysm is prescribed at any age of the pregnancy. If the bleeding is due to an AVM rupture, the best procedures are yet to be defined, and the therapeutic choice should be made on a case-by-case basis. In a patient with a brain tumor, surgery may be deferred until gestational period reaches at least its 30 th week. If the patient presents with neurological deterioration, surgery is immediately performed to save the mothers' life.
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